Causal Associations of Sjögren's Syndrome with Cardiovascular Disease: A Two-sample Mendelian Randomization Study

Overview

Journal Am Heart J Plus

Specialty Cardiology & Vascular Diseases

Date 2024 Nov 18

PMID 39554979

Authors

Chen Su

Xiaobo Zhu

Qiang Wang

Feng Jiang

Junjie Zhang

Affiliations

Soon will be listed here.

Abstract

Study Objectives: Observational and cohort studies have associated Sjögren's syndrome (SS) with various types of cardiovascular disease (CVD), yet causal relationships have not been established. We employed Mendelian randomization (MR) to investigate potential causal links between SS and CVD in the general population.

Methods: We conducted a two-sample MR analysis using data from four distinct sources for 11 genome-wide significant single nucleotide polymorphisms (SNPs) associated with SS and data for 13 types of CVD sourced from FinnGen, IEU OpenGWAS, and GWAS catalog. The inverse variance weighted method was selected as the primary analytical approach, complemented by various sensitivity analyses.

Results: MR analyses provide evidence of a significantly increased risk of ischemic stroke associated with genetically predicted SS (odds ratio [OR], 1.0237; 95 % CI, 1.0096 to 1.0379; = 0.0009), as well as suggestive evidence of a potential causal relationship between SS and an increased risk of chronic heart failure (OR, 1.0302; 95 % CI, 1.0020 to 1.0592; = 0.0355). Sensitivity analyses reinforced these associations, demonstrating robustness and consistency across multiple statistical methods. The secondary analysis, conducted after outlier correction using MR-PRESSO and RadialMR methods, reaffirmed these associations and also indicated a suggestive causal link between SS and non-rheumatic valvular heart disease (OR, 1.0251; 95 % CI, 1.0021 to 1.0486; = 0.0323).

Conclusions: This study demonstrates that genetically predicted SS is a potential causative risk factor for ischemic stroke, chronic heart failure, and non-rheumatic valvular heart disease on a large-scale population. However, further research incorporating ancestral diversity is required to confirm a causal relationship between SS and CVD.

References

Davies K, Ng W . Autonomic Nervous System Dysfunction in Primary Sjögren's Syndrome. Front Immunol. 2021; 12:702505. PMC: 8350514. DOI: 10.3389/fimmu.2021.702505. View

Bridge K, Farivar R . A case of Sjögren's syndrome leading to mitral and aortic valve replacement. J Thorac Cardiovasc Surg. 2010; 139(6):e139-40. DOI: 10.1016/j.jtcvs.2009.11.068. View

Burgess S, Small D, Thompson S . A review of instrumental variable estimators for Mendelian randomization. Stat Methods Med Res. 2015; 26(5):2333-2355. PMC: 5642006. DOI: 10.1177/0962280215597579. View

Sedgwick P . Multiple hypothesis testing and Bonferroni's correction. BMJ. 2014; 349:g6284. DOI: 10.1136/bmj.g6284. View

Ross R . Atherosclerosis--an inflammatory disease. N Engl J Med. 1999; 340(2):115-26. DOI: 10.1056/NEJM199901143400207. View

Kurki M, Karjalainen J, Palta P, Sipila T, Kristiansson K, Donner K . FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023; 613(7944):508-518. PMC: 9849126. DOI: 10.1038/s41586-022-05473-8. View

Berger M, Fesler P, Roubille C . Arterial stiffness, the hidden face of cardiovascular risk in autoimmune and chronic inflammatory rheumatic diseases. Autoimmun Rev. 2021; 20(9):102891. DOI: 10.1016/j.autrev.2021.102891. View

Khatri B, Tessneer K, Rasmussen A, Aghakhanian F, Reksten T, Adler A . Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells. Nat Commun. 2022; 13(1):4287. PMC: 9329286. DOI: 10.1038/s41467-022-30773-y. View

Chivasso C, Sarrand J, Perret J, Delporte C, Soyfoo M . The Involvement of Innate and Adaptive Immunity in the Initiation and Perpetuation of Sjögren's Syndrome. Int J Mol Sci. 2021; 22(2). PMC: 7826728. DOI: 10.3390/ijms22020658. View

10.

Higgins J, Thompson S, Deeks J, Altman D . Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414):557-60. PMC: 192859. DOI: 10.1136/bmj.327.7414.557. View

11.

Burgess S, Butterworth A, Thompson S . Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013; 37(7):658-65. PMC: 4377079. DOI: 10.1002/gepi.21758. View

12.

Bucci T, Cardamone C, Triggiani M, Ames P, Lip G . Risk of death, thrombotic and hemorrhagic events in anticoagulated patients with atrial fibrillation and systemic autoimmune diseases: an analysis from a global federated dataset. Clin Res Cardiol. 2024; 113(6):942-950. PMC: 11108877. DOI: 10.1007/s00392-024-02426-1. View

13.

Izmirly P, Buyon J, Wan I, Belmont H, Sahl S, Salmon J . The Incidence and Prevalence of Adult Primary Sjögren's Syndrome in New York County. Arthritis Care Res (Hoboken). 2018; 71(7):949-960. PMC: 6347539. DOI: 10.1002/acr.23707. View

14.

Bowden J, Davey Smith G, Haycock P, Burgess S . Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016; 40(4):304-14. PMC: 4849733. DOI: 10.1002/gepi.21965. View

15.

Taylor K, Wong Q, Levine D, McHugh C, Laurie C, Doheny K . Genome-Wide Association Analysis Reveals Genetic Heterogeneity of Sjögren's Syndrome According to Ancestry. Arthritis Rheumatol. 2017; 69(6):1294-1305. PMC: 5449251. DOI: 10.1002/art.40040. View

16.

Timmis A, Townsend N, Gale C, Torbica A, Lettino M, Petersen S . European Society of Cardiology: Cardiovascular Disease Statistics 2019. Eur Heart J. 2019; 41(1):12-85. DOI: 10.1093/eurheartj/ehz859. View

17.

Xue H, Shen X, Pan W . Constrained maximum likelihood-based Mendelian randomization robust to both correlated and uncorrelated pleiotropic effects. Am J Hum Genet. 2021; 108(7):1251-1269. PMC: 8322939. DOI: 10.1016/j.ajhg.2021.05.014. View

18.

Bolstad A, Skarstein K . Epidemiology of Sjögren's Syndrome-from an Oral Perspective. Curr Oral Health Rep. 2016; 3(4):328-336. PMC: 5104792. DOI: 10.1007/s40496-016-0112-0. View

19.

Shoenfeld Y, Sherer Y, Harats D . Artherosclerosis as an infectious, inflammatory and autoimmune disease. Trends Immunol. 2001; 22(6):293-5. DOI: 10.1016/s1471-4906(01)01922-6. View

20.

Alunno A, Carubbi F, Mariani F, Martini C, Campanozzi E, Ferri C . The Interplay between Cardiovascular Risk, Cardiovascular Events, and Disease Activity in Primary Sjögren's Syndrome: Is Uric Acid the Missing Link?. Nutrients. 2023; 15(7). PMC: 10096655. DOI: 10.3390/nu15071563. View